Aratana Therapeutics Adds to Management Team
Aratana Therapeutics, a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, appointed Craig Tooman as chief financial officer and John C. Ayres as its general counsel.
“Aratana has grown considerably over the past year, having successfully completed our initial public offering in June and now, with the acquisition of Vet Therapeutics, becoming a commercial company,” Steven St. Peter, president and CEO, said. “The appointments of Craig Tooman and John Ayres, both highly experienced commercial biopharmaceutical executives, will substantially enhance our strategy to establish Aratana as the industry leader in pet therapeutics.”
Louise Mawhinney, former CFO of Aratana, will remain with the company.